SecBot SecBot
8-K ·Filed Mar 5, 2026

CELU

Celularity Inc
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago SEC0001493152-26-009017
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for future filings regarding permanent CFO appointment or financial updates; no immediate trading implications from this personnel change.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CELU ▼ -11.57% at T+60d
NEUTRAL call -11.57% · α vs SPY -24.35% · entry $1.21 → $1.07
Entry = T+0 close
Mar 5, 2026
via day close
T+1d
+3.31%
call +3.31% · α +2.46%
$1.25
settled 8mo ago
T+5d
+0.83%
call +0.83% · α +2.35%
$1.22
settled 8mo ago
T+20d
+15.70%
call +15.70% · α +17.75%
$1.40
settled 7mo ago
T+60d
-11.57%
call -11.57% · α -24.35%
$1.07
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Celularity Inc. announced the departure of Joseph DosSantos as SVP, Finance and Acting CFO for personal reasons, and the appointment of John Sprague as Acting CFO on February 27, 2026. This is a routine executive transition with no immediate financial implications disclosed.

Key Facts

  • Joseph DosSantos departed as SVP, Finance and Acting CFO for personal reasons
  • John Sprague was appointed Acting CFO effective February 27, 2026
  • No financial data, compensation details, or long-term CFO search plans were disclosed
  • The filing is limited to personnel changes under Item 5.02

Financial Impact

No direct financial impact disclosed

Risk Factors

  • Potential leadership instability during transition period
  • Lack of disclosed succession planning details

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-009017
Document: 0001493152-26-009017-index-headers.html0001493152-26-009017
Document: 0001493152-26-009017-index.html0001493152-26-009017
Document: 0001493152-26-009017.txt0001493152-26-009017
15 reports for CELU
Performance horizon
67% Hit rate @ T+60 2 of 3 directional calls Went positive at some point 5 of 8 best @ T+20▲ +46.43%Sep 28, 2026
Filters
Rows
Reports for CELU — sortable, filterable
TypeNow
Oct 20, 2026
7d ago
10-K/A
BEARISH ★ 5/10
$1.26awaiting T+60—$0.7800 (+38.10%)
Sep 30, 2026
26d ago
Press Release
NEUTRAL ★ 4/10
$1.35awaiting T+60—$0.7800 (−42.22%)
Sep 29, 2026
27d ago
8-K
NEUTRAL ★ 4/10
$1.35awaiting T+60—$0.7800 (−42.22%)
Sep 28, 2026
28d ago
SC 13D/A
BEARISH ★ 7/10
$1.40awaiting T+60—$0.7800 (+44.29%)
Sep 28, 2026
29d ago
8-K
BEARISH ★ 7/10
$1.40awaiting T+60—$0.7800 (+44.29%)
Sep 24, 2026
4w ago
Press Release
MIXED ★ 6/10
$1.32awaiting T+60—$0.7800 (−40.91%)
Sep 14, 2026
6w ago
8-K
MIXED ★ 5/10
$1.40awaiting T+60—$0.7800 (−44.29%)
Aug 25, 2026
8w ago
Press Release
BEARISH ★ 7/10
$0.8804awaiting T+60—$0.7800 (+11.40%)
Aug 7, 2026
11w ago
8-K
BEARISH ★ 5/10
$0.6866awaiting T+60—$0.7800 (−13.60%)
Jun 30, 2026
17w ago
8-K
BEARISH ★ 6/10
$0.5979 $1.15▼ −92.34%▼ −88.78%$0.7800 (−30.46%)
Showing 10 of 15

US Market Status

Market Open — Closes in 5h 46m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 5, 2026